Skip to content

Pimecrolimus

Skin & Dermatology
Save $104/mo
6× cheaper

Pimecrolimus Cream, 1% is indicated as second-line therapy for the short-term and non-continuous chronic treatment of mild to moderate atopic dermatitis in non-immunocompromised adults and children 2 years of age and older, who have failed to respond adequately to other topical prescription treatmen…

United States
$126
per month
India
$22
per month
You save
−83%
save $104/mo · 83% cheaper
70.7K US scripts/yr$7.3M potential annual savings$8.9M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC43H68ClNO11

SMILES: CC[C@@H]1/C=C(/C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC1=O)O)C)/C(=C/[C@@H]4CC[C@@H]([C@@H](C4)OC)Cl)/C)O)C)OC)OC)C)\C

Compare the price
US price$126per month
India price$22per month
You save$10483% less

Based on 30 units per month. US $4.19 vs India $0.73 per unit.

Total over 1 periodSave $104$126$22
The bigger picture

Pimecrolimus is filled about 70.7K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$8.9M
If sourced from India
$1.5M
Potential annual savings
$7.3M
83%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.